Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 (TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively. Debutyldronedarone hydrochloride can be used for the research of arrhythmic.
性状
Solid
IC50 & Target[1][2]
TRα1/TRβ1
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
4°C, sealed storage, away from moistur In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
参考文献
[1]. Van Beeren HC, et al. Dronerarone acts as a selective inhibitor of 3,5,3-triiodothyronine binding to thyroid hormone receptor-alpha1: in vitro and in vivo evidence. Endocrinology. 2003 Feb;144(2):552-8.